Please login to the form below
IGAS
This page shows the latest IGAS news and features for those working in and with pharma, biotech and healthcare.
Incyte’s JAK inhibitor cream clears second eczema trial
In both trials, significantly more patients treated with ruxolitinib cream (0.75% or 1.5%) achieved Investigator’s Global Assessment Treatment Success (IGA-TS) than patients treated with a control ... Success was defined as an IGA score of 0 (clear skin
Latest news
-
Sanofi indicted in France over epilepsy drug birth defects
The following year, France’s social affairs inspection agency IGAS took issue with what it said was a slow response by the health authorities and Sanofi to updating the labelling of ... IGAS has estimated that between 2006 and 2014, somewhere between
-
UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial
investigator global assessment (IGA) response of clear or almost clear.
-
J&J's Tremfya filed for approval in US for psoriatic arthritis
CRP), improvement in physical function (HAQ-DI), skin clearance (IGA) and quality of life (SF-36 PCS and MCS).
-
Tremfya heads for filing in psoriatic arthritis
DAS-28 CRP), improvement in physical function (HAQ-DI), skin clearance (IGA), and quality of life (SF-36 PCS and MCS).
-
Swedish biotech Calliditas signs China licensing deal for autoimmune candidate
Nefecon is a novel oral formulation of the corticosteroid budesonide which targets the active ingredient to B cells in the lower small intestine and control the output of IgA antibodies. ... Calliditas has one competitor in the field, Omeros, which is
More from news
Approximately 1 fully matching, plus 14 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Hayward Medical Communications launch a new, eye-opening journal
Hayward is particularly pleased that the journal features regular columns from the International Glaucoma Association (IGA) and the Royal National Institute of Blind People (RNIB). .
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- Amgen adds Otezla to the COVID-19 candidate list
- UK clears NHS use of Gilead’s remdesivir for COVID-19 patients
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- NICE approves Roche’s Tecentriq in TNBC after revising deal
- CEPI-backed coronavirus vaccine from Novavax starts trials
- IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- The big issue
- The field team are off the road! What should they do next?
- INFOGRAPHIC 02: The Importance of clinical study websites
PMHub
mXm Medical Communications
mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...
Latest intelligence
- The big issue
- Whether you want to lead or follow, you need to understand the elephant in the C-suite...
- INFOGRAPHIC 02: The Importance of clinical study websites
- Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
- Working with, Advocating for, and Empowering Patients
- A holistic view of how to work with patients virtually...
Quick links
Infographics
